الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

medstone pharma llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

bryant ranch prepack - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

quality care products, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - codeine phosphate hemihydrate 9.75mg; doxylamine succinate 5mg;  ;  ; paracetamol 450mg;   - tablet - 9.75mg/5mg/450mg - active: codeine phosphate hemihydrate 9.75mg doxylamine succinate 5mg     paracetamol 450mg   - for patients over the age of 12 for the symptomatic relief of acute moderate to severe pain including headache, toothache, backache or pain associated with trauma or surgery. the calmative properties may be especially useful in the treatment of tension headache, migraine and period pain and the antipyretic properties may be useful in controlling fever. mersyndol is a suitable alternative for those individuals who cannot tolerate aspirin.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol succinate 190mg equivalent to 77.69 mg free drug base;  ;   - modified release tablet - 190 mg - active: metoprolol succinate 190mg equivalent to 77.69 mg free drug base     excipient: colloidal silicon dioxide hypromellose macrogol 6000   magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc   sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base;  ;   - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg equivalent to 9.71 mg free drug base     excipient: colloidal silicon dioxide hypromellose macrogol 6000   magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc   sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol succinate 47.5mg equivalent to 19.42 mg free drug base;  ;   - modified release tablet - 47.5 mg - active: metoprolol succinate 47.5mg equivalent to 19.42 mg free drug base     excipient: colloidal silicon dioxide hypromellose macrogol 6000   magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc   sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol succinate 95mg equivalent to 38.84 mg free drug base;  ;   - modified release tablet - 95 mg - active: metoprolol succinate 95mg equivalent to 38.84 mg free drug base     excipient: colloidal silicon dioxide hypromellose macrogol 6000   magnesium stearate microcrystalline cellulose polyacrylate dispersion 30% povidone purified talc   sugar spheres titanium dioxide - hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. paediatric hypertension

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hhs/program support center/supply service center - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.